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Cobra venom as a lytic and anticomplementary substance has been known since 
1900  (1).  More  recently,  Nelson  (2)  separated  a  nontoxic component of  cobra 
venom and showed that it was selective in its action in that only C3c was destroyed. 
Nelson also recognized that a serum cofactor was essential to the inactivation  of the 
complement system by the purified cobra venom factor (CVF) 1 and Mfiller-Eber- 
hard  and  his  associates  (3)  defined a  proinactivator, a  5S  pseudoglobulin of  a 
3,-mobility in human serum essential to the inactivation of the complement system. 
Consonant with early work on the hemolytic action of cobra venom, Pickering et al. 
(4,  5)  showed that this purified cobra venom factor eluted from a  single protein 
band on polyacrylamide gel can produce lysis of guinea pig red blood cells in the 
presence of fresh serum. This lyric activity was shown to be a function of the ter- 
minal components of the complement system and was found not to involve any of 
the complement components which act in the earlier steps of the complement cas- 
cade  when  the  system  is  activated by  antigen-antibody complex.  Subsequently 
Ballow and Cochrane (6)  have confirmed these findings and Shin et al.  (7)  have 
reported  that  acting through  the proinactivator of  the  complement system,  the 
cobra venom factor inactivates C5, 6, 7, 8, and 9 in vitro. 
These studies established that the cobra venom factor can utilize the entire ter- 
minal complement sequence and release chemotactic factors from C3 and C5 with- 
out engaging the earlier components. These observations are in keeping with studies 
by Gewurz et al. (8, 9) and Mergenhagen et al. (10) which had indicated that the 
complement sequence can be activated by separate pathways which differ from the 
classical immunological mechanism of  activation. In the present study we  have 
applied the cobra venom factor pathway to study the complement system in the 
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sera of lower vertebrates  and hemolymphs  of critical evolutionary representatives 
of invertebrates. 
The presence  of C  in lower vertebrates  has  been described  by several inves- 
tigators  (11-15).  However,  complement  in  more  primitive  fishes  (hagfish, 
lamprey)  was  not demonstrable  by  classical methods  (16).  Nelson  (17),  how- 
ever,  showed  that  lamprey  serum  possesses  the  9th  component.  No  evidence 
of  the  presence  of  C  or  C  components  has  been  previously  described  in  the 
hemolymph  of  invertebrates.  In  the  studies  to  be  presented,  we  have  shown 
that  both  lower vertebrates  and  invertebrates  possess  a  lytic  C  system  which 
can be activated via a  pathway  initiated  by the  cobra venom factor. 
Materials and Methods 
Vertebrate and Invertebrate Species Studied.--The  vertebrate species  studied were phylo- 
genetic representatives of the Agnatha Petromyzon marinus  (sea lamprey) obtained from the 
U.S.  Bureau  of Commercial Fisheries, Hammond  Bay,  Millersburg, Mich.;  the Eptatratus 
stoutii  (hagfish)  from  Pacific Biomarine,  Venice,  Calif.;  the  Condrichthyes  Ginglymostoma 
cirratus  (nurse  shark)  from  Miami  Seaquarium,  Miami,  Fla.;  the  chondrostean  Polyodon 
spathula (paddlefish)  from the South Dakota Division of Game Fisheries and Parks, Woon- 
socket,  S. Dak.;  and  the teleost  Cyprinus  carpio (carp),  Minn.  Conservation,  Division of 
Game  and  Fisheries, St.  Paul,  Minn.  Two speies  of  the amphibia Rana  pipiens  (leopard 
frog) and Rana  catesbeiana (bullfrog)  were inccluded.  Representative species  of the reptilia 
were the Chelydra serpentina (snapping turtle) and Naja haje (Egyptian cobra). The frogs and 
turtles were obtained from Schettles, Stillwater, Minn. and the cobra serum from Ross Allen's 
Repti[e Institute,  Silver Springs,  Fla. The chicken represented  the Ayes. For comparative 
purposes,  the guinea pig was included in this study. The invertebrate species  were selected 
from two marine stocks of the trploblastic phyla. The one stock leading to the  insecta was 
represented by a primitive arthroipod Limulus polyphemus (horseshoe crab) and a representa- 
tive of the Sipunculoidea Golfingea sp (sipunculid  worm). Of the second stock leading to the 
vertebrata, Asterius forbesi (starfish)  represented  the Echinodermata.  The invertebrate spe- 
cies were obtained from the Marine Biological Laboratories, Woods Hole, Mass. 
A nticomplementary Substanees.--Equal  volumes of the anticomplementary substances were 
incubated  with equal volumes of test  sera.  The mixtures were incubated for  1 hr  at 30°C 
and tested for anticomplementary activity. Endotoxin: 0.1 mg/ml (Difco product lipopoly- 
saccharide  S.  typhosa,  Batch 3124-10  [Difeo Laboratories,  Inc., Detroit,  Mich.]).  Antigen- 
antibody complexes were made with BSA and rabbit anti-BSA at the zone of equivalence. 
The resulting precipitate was washed several times with isotonic saline and  resuspended  to 
give approximately 2 mg protein/ml. 
Salycylaldoxime, Congo red, hydrazine, and EDTA were obtained from Eastman Organic 
Chemicals,  Rochester, N.Y.  Zymosan was  activated as described by Mayer  (18) and  pur- 
chased from Nutritional Biochemicals Corp., Cleveland, Ohio, Batch No. 5818. 
Purification  of Cobra Venom.--Crude  cobra venom Naja haje was obtained in the lyophi- 
lized state from the Miami Serpentarinm, Miami, Fla., and purified as described by previous 
investigators (2). The final product was analyzed by disc electrophoresis and  shown to have 
anticomplementary and lyric activity with guinea pig serum. This product was shown not to 
contain any phospholipase activity. 
Measurement of Total Hemolytic Complement in  Vertebrate Sera.--Gelatin  veronal buffer, 
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prepared  as  described  previously  (19).  Sensitization of erythrocytes from  sheep  and from 
rabbit, depending on  the species used  and  the measurement  of  CHs0, has been described 
earlier (15). 
Assay System for Measuring Anticomplementary Activity in Lower Vertebrates.--0.1 ml of 
test serum was preincubated with 0.1 ml of purified CVF for 18 hr at 0°C; after this period, 
0.8 ml GGV  ++ was added and the dilutions of the mixture were made in 0.5 ml volume. 0.5 
ml of respective indicator cells sensitized with rabbit amboceptor or natural antibody, de- 
pending on the species tested  (15),  were added and the mixture incubated for 1 hr at 30°C 
or for 18 hr at 0°C. To determine the per cent lysis, 6.5 ml saline were added. The mixtures 
were centrifuged and  the supernates read spectrophotometrically at 412 m#. The CH~0 was 
determined by interpolation in the usual way. 
Measurement of the Lytic Activity of CVF.--Dilutions of sera were made in 0.5 ml volume 
in GGV  ++. To each tube 0.1 ml of CVF was added. 0.5 ml of sheep cry.  throcytes (E~), rabbit 
erythrocytes (Erb), or  horse erythrocytes  (E  h) were added  next. The tubes were incubated 
for 1 hr at 30°C, diluted, and the CHs0 measured. 
Complex Formation.--To test for complex formation in the sera of different animals stud- 
ied, equal amounts of CVF and serum or hemolymph were incubated for ~ hr at 30°C.  This 
phase is defined as step I  (Fig.  1).  The lyric activity of the complex was tested by adding 
0.1 ml of complex to tubes containing dilutions of fresh serum in 0.05 ~t EDTA in the pres- 
ence of erythrocytes. This phase is defined as step II. The lyric activity of the complex was 
of a  greater magnitude than the lyric activity of the control CVF-normal saline mixture at 
that molarity of EDTA. The latter mixture had either very low activity or was not present at 
all. 
Interaction of CVF with Hemolymphs  from Invertebrates.--Hemolymph from the sipunculid 
worm was obtained from the coelomic cavity. From Limulus polyphemus, the fluid was with- 
drawn by inserting the syringe under the carapace into the dorsal sinus, and from the starfish 
by inserting the needle into the ambulacrai canal (groove). In bleeding the starfish greater 
efficiency was obtained when the animal was tilted toward the astro. Hemolymphs from the 
starfish and horseshoe crab were centrifuged at 10,000 rpm for 20 min in a Sorvall ultracentri- 
fuge (Ivan Sorvall, Inc., Norwalk, Conn.) Superspeed RC2-B, and the superuates were used 
for study. Dilutions of hemolymph was made in GGV  ++ in 0.5 ml volume. 0.1 ml of CVF was 
added to each tube followed by 0.5 ml of E  (E  s or  Erb). The mixtures were incubated for 1 
hr at 30°C  and the tubes were left overnight for 18 hr at 0°C and treated as above for the 
determination of CHs0. 
RESULTS 
Lysis-Inducing  Activity of Purified  Cobra  Venom Factor  on  Vertebrate Sera 
and Invertebrate  ttemolymphs  and Complement Consumption  of Vertebrate Sera 
by Purified Cobra Venom Factor.--Table I  represents observations on the lysis- 
inducing activities (LIA)  of purified cobra venom factor on various vertebrate 
sera and invertebrate hemolymphs. As indicated in the Table, LIA  was present 
in  the  sera  of  the  guinea pig  and  chicken,  and  was  extremely  marked  in  the 
frog.  Further  LIA  was  observed  with  hagfish  serum  and  in  two  of  the  three 
invertebrate  hemolymphs,  i.e.,  horseshoe  crab  and  sipunculid  worm.  By  con- 
trast LIA  was  absent in sera from turtle,  cobra,  carp,  paddlefish,  nurse shark, 
and lamprey,  and from  starfish hemolymph.  In  the horseshoe  crab,  LIA  was 
labile even on storage  at  --70°C.  The  anticomplementary  activity  of  purified 
CVF  was  present  in  mammalia  (guinea  pig),  ayes  (chicken),  reptilia  (turtle, 944  COMPLEMENT  IN  LOWER  VERTEBRATES  AND  INVERTEBRATES 
cobra),  amphibia  (marine frog,  bullfrog),  and  in one species  of  the chondrich- 
thyes  (nurse  shark).  No  anticomplementary  effect  on  sera  of  teleosts  (carp) 
and  chondrostean  (paddlefish)  was  found.  Measurement  of  total  complement 
activity  in  the  above species has  already  been described  (15). 
TABLE  I 
Lysis-inducing Activity  of Purified Cobra Venom Factor on  Vertebrate Sera and Invertebrate 
Hemolymphs and C Consumption of Vertebrate Sera by Purified CVF 
Total hemolytic  Lysis-inducing  C-consum-  ing ac-  Category  Species  C activity (cn~0)*  activity (LIA6~):~  tivity§ 
Vertebrates 
Mammalia 
Ayes 
Reptilia 
Amphibian 
Osteichthyes 
Chondrichthyes 
Agnatha 
Guinea pig  1500-2000  40-80  > 95 
Chicken  52-90  110-160  > 95 
Cobra  150-200  < 5  > 95 
Turtle  2000-3000  < 5  > 95 
Frog  300-500  1000-1500  >95 
Carp  100-150  < 5  0 
Paddlefish  50-75  < 5  0 
Nurse shark  300-400  < 5  > 95 
Lamprey  < 2  < 5  -- 
Hagfish  < 2  20-40  -- 
Invertebrates 
Arthropod  Horseshoe crab  < 2  12-24  -- 
Echinoderm  Starfish  N.D.  > 5  -- 
Annelid  Sipunculid worm  < 2  2.5-5.0  -- 
* Reaction mixtures were incubated for  I  hr at 30°C,  6.5 ml of saline was added  and, 
after centrifugation,  the hemoglobin released was  determined spectrophotometrically.  The 
CHs0 was determined by interpolation. 
Lysis-inducing activity of purified cobra venom factor.  Test sera were diluted in glu- 
cose gelatin buffer containing Ca  ++ and Mg  ++ ions. 0.1  ml of purifed CVF was added  to 
each tube. 0.5 ml of erythrocytes was added next. The mixtures were incubated at 30°C for 
1 hr.  When invertebrate hemolymph was used,  an additional incubation at 0°C  for  18 hr 
was included. The dilution and release of hemoglobin was determined as for CH~0. 
§ Complement consumption of  vertebrate sera  by  purified  cobra venom factor  (CVF). 
Equal volumes of CVF and test sera were preincubated for 1 hr at 30°C,  and the residual 
CHs0 determined. 
Effect of Preformed Complexe~ (C VF +  Frog Serum) on Frog Serum in EDTA. 
--To  further elucidate the nature of LIA  in the lower vertebrates,  we used the 
frog  as  a  model.  Since  we  cannot  at  present  measure  terminal  complement 
components in frog serum directly,  experiments were set up to test further the 
nature  of  the  influence  of  CVF  in  promoting  lysis  of  indicator  cells  in  frog 
serum.  Complex  was  produced  by  reacting  CVF  with  frog  serum  for  2  hr. DAY,  GEWURZ~  JOHANNSEN,  FINSTAD~  AND  GOOD  945 
When this complex was reacted with frog serum in 0.05 ~  EDTA in the pres- 
ence of  sheep erythrocytes  (E~),  lysis was  obtained. In Fig.  1,  the formation 
of the complex is defined as step I and the reaction of the complex with C'EDTA 
as step II. These results would indicate that terminal complement components 
are necessary for red cell lysis by CVF in frog serum. 
Me  +l" 
STEP  I  +  CVF  ,- 
STEP II  ~  +  EDTA  +  RBC 
FIG. 1. Steps involved in the lysis-inducing activity of purified cobra venom factor (CVF) 
and their relation to serum factors and divalent cations (Me++). 
TABLE  II 
Effect of Known Inhibitors of Mammalian Hemolytic Complement Activity upon Lysis-inducing 
Activity in the Frog 
Total hemo-  Lysis-inducing activity 
Agent  Final concentration  lyric C 
activity  Total  Step I  Step II  LIAs0 
Zymosan  30 mg/ml  > 90  > 90  < 5  > 90 
Heat  56°C, 30 min  >90  >90  90  >90 
CVF  1 mg/ml  >90  >90  <5  >90 
Hydrazine  0.07 M  >90  20  <5  20 
Lipopolysaccharide  25 mg/ml  >90  >90  <5  >90 
Salycylaldoxime  0.1 ~  >90  >90  < 5  >90 
Congo red  20 mg/ml  >90  >90  <5  >90 
EDTA  0.04 u  >90  80  90  -- 
Antigen-antibody  2 mg/ml  60  70  < 5  70 
The figures represent  percentage  inhibition of lysis-inducing activity by C  inhibitors. 
Test sera were preincubated with known concentrations of inhibitors at 30°C for 1 hr and 
the residual CH~0 and LIAs0 were determined. Wherever total C was inhibited, LIA was 
also inhibited except when hydrazine was used. 
Step I and Step II represent the two phases of lysis-inducing activity (Fig. 1). As shown, 
only heat and EDTA affected Step I, suggesting that during the formation of the complex, 
divalent cations are required and the serum factor(s) necessary to form the complex is (are) 
heat labile. 
Inhibition by all C inhibitors except hydrazine was evident in Step II. 
Effect of C Inhibitors on Lysis-Inducing Activity by Purified CVF and by Pre- 
formed  Complex  (CVF +  Frog Serum).--In  order  to  determine whether  the 
lysis-inducing activity either by CVF alone or by preformed complex (CVF + 
frog  serum)  was  C-dependent, experiments were  set  up with known comple- 
ment inhibitors (Table II). As demonstrated in guinea pig serum, when frog 
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plement function including Congo red, salycylaldoxime, endotoxin (Salmonella 
typhosa),  EDTA,  CVF,  and heat, both classical C  and lysis-inducing activities 
were  inhibited.  Hydrazine,  however,  which  is  known  to  inactivate  the  com- 
plement  system  by action  at  the  4th  component,  did  not  inhibit  LIA either 
when  total LIA was measured  or at  the Step II phase.  With  the exception of 
heat and  EDTA,  there was no effect of C  inhibitors  ~t the  Step I  phase. 
Interchangeability  of Invertebrate  and  Vertebrate  Serum  Factors.--The  inter- 
changeability of frog and invertebrate  components in the induction of LIA by 
CVF  are presented  in Table  III. Complexes were formed by using  CVF and 
various  vertebrate  sera  and  invertebrate  hemolymphs  (step  I).  For  step  II 
frog serum in EDTA was provided. We observed that CVF-frog, CVF-limulus, 
and  CVF-starfish complexes induced lysis of E s in the presence of frog serum. 
TABLE III 
Interchangeability of Frog Sera and Invertebrate Hemolymph  Components in the Induction  of 
Lysis-inducing Activity by Purified Cobra Venom Factor 
Species tested  Total LIA60*  Step I~t  Step II§  (frog 2 provided)  (frog 1 provided) 
Guinea pig  40-80  < 5  < 5 
Frog  1000-1500  > 10  300-400 
Starfish  < 5  > 10  < 5 
Horseshoe crab  12-24  > 10  10-20 
* Total lysis-inducing activity (as in Table I). 
:~ Step I. Preformed complex formed with various species and reacted with erythrocytes 
and frog serum in 0.05 M EDTA. 
§ Step II. Complexes formed with frog serum and purified cobra venom factor and reacted 
with sera in EDTA from various species in the presence of red blood cells. 
No  lysis  was  obtained  when  guinea  pig-CVF  complex  was  employed.  Most 
striking  observations  were  observed  when  complexes  formed  with  starfish 
hemolymph and CVF were reacted with frog serum in EDTA. The magnitude 
of lysis observed was similar  to LIA when step I  consisted  of frog-CVF com- 
plex.  Starfish  hemolymph  added  to  frog  serum  with  E ~ did  not  show  lysis. 
At  the  molarity  of  EDTA  used  with  frog  serum,  CVF  alone  was  inactive. 
Moreover, the lysis was C-dependent as studied by use of inhibitors. Therefore, 
it  seems  that  we  were  dealing  with  a  complex  of  CVF  and  a  component of 
starfish  hemolymph  capable  of  activating  the  terminal  components  of  frog 
serum.  When  frog complex was  provided  to various  sera  and  hemolymph  in 
EDTA  (step II), lysis was observed with frog serum and  limulus hemolymph 
in the presence of EDTA and E s. 
DISCUSSION 
Classical  complement was  measurable  in  sera  of  all  the  vertebrate  species 
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activity of purified CVF  was  not always demonstrable.  By contrast,  in hag- 
fish where classical C has never been found, LIA was observed. In sera of cobra, 
turtle, and nurse shark, anticomplementary activity but not LIA was present, 
and  in  carp  and  paddlefish,  neither  was  demonstrable  after  treatment  with 
purified CVF. A possible explanation is that an inhibitor to the lyric activity 
induced by CVF is present in sera of some species. It has been shown by pre- 
vious investigators that in mammals CVF interacts with a serum 5S proinac- 
tivator forming a  complex which in turn activates C3  and the terminal com- 
ponents (2, 3). 
Striking results were obtained with LIA of CVF when frog serum was used. 
Indeed a higher titer of lytic activity was obtained when CVF was the activator 
than when sheep cells sensitized with the rabbit antibody were exposed to frog 
serum.  Because this  system for studying lyric function of cobra venom was 
highly reproducible we concentrated on the frog to determine whether the lysis 
of E s produced with CVF was C-dependent. Our data shows that all inhibitors 
known to deplete total C activity depleted LIA also. These findings are similar 
to those previously reported in the guinea pig system when LIA was initiated 
with CVF. 
Perhaps the most challenging observations are with those animals which do 
not seem to possess classical complement, i.e.,  the primitive cyclostome (hag- 
fish) and invertebrates.  LIA was demonstrable  in  hagfish  serum  and  in  the 
hemolymph of two of the  three invertebrates studed. These findings suggest 
that components perhaps homologous to terminal C components of mammals 
may be recognizable when the alternate CVF pathway is used to activate this 
system. 
We also showed in the frog that a complex formed with CVF and frog serum 
was essential, as in the guinea pig, to activate the lyric or "attack" components 
of the complement system. Indeed, preformed complex initiated lysls in the 
presence of frog serum treated with EDTA.  This complex-induced lysis was 
also  shown  to be  inhibited  by known  inhibitors  of the  complement system. 
Formation of the complex was  independent of the  complement system even 
though it required divalent cations. Complexes formed with hemolymph of the 
horse shoe crab and CVF induced lysis of E s in the presence of EDTA-treated 
frog serum.  This  complex also  induced  lysis  of E s in  EDTA-treated hemo- 
lymph of the horse shoe crab.  CVF complex formed with frog serum induced 
lysis  in EDTA-treated hemolymph of the crab.  Starfish hemolymph treated 
with CVF induced lysis of E ~ in EDTA-treated frog serum and the titer of the 
lytic reaction was comparable to that obtained when CVF-frog serum complex 
was introduced with E s in EDTA-treated frog serum. The latter lyric reaction 
was  also  shown by complement inhibitors  to be dependent  on  the  terminal 
components of the frog complement. 
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with  complement are  present in lower vertebrates,  e.g.  the frog,  and similar 
activities are present  in  representatives of several lines of invertebrates spe- 
cifically chosen to be widely divergent phylogenetically. 
Many studies have been performed to determine whether invertebrates have 
classical adaptive immune responses (20,  21). As yet, even though suggestive 
evidence has been obtained for the existence of cellular immunity in the earth- 
worm  (22),  no  clear  evidence of  immunoglobulin  or  true  adaptive  antibody 
responses have been presented for invertebrates. This conclusion involves the 
hazards  of negative  evidence,  but from studies  thus far  the burden  remains 
squarely on those who contend that invertebrates possess adaptive immunity 
comparable  to  that  of  mammals.  Studies  from  our  laboratories  (23,  24)  as 
well as  by others  (25-28)  indicate  that  the  complement system may play a 
role  in  inflammatory reactions  under  circumstances  where  initiation  by the 
classical immune pathway is not involved. With  this evidence and that from 
studies reported here,  it is  attractive  to  think  of the  complement system as 
being  more primitive  than  the  immune  system  itself.  This primitive system 
which  can be activated by the cobra venom factor may not even have been 
originally related to immunity as it is conventionally considered. Could it be, 
for example,  that  this more ancient complement system readily activated by 
CVF,  especially when complexed with a serum factor, was a  system involved 
in  the bodily defense through  its  relation  to inflammation  and  phagocytosis 
to which the more latterly developing classical immunity system was linked by 
the imposition of the earlier complement components C1, 4,  and 2? Such a de- 
velopmental mechanism would,  indeed,  be a  natural  mechanism for utilizing 
the  primitive  defense reactions  of phagocytosis,  inflammation,  and  vascular 
response  to  amplify certain  of  the  specific  combining  characteristics  of  the 
adaptive immune responses. 
SUMMARY 
A purified cobra venom factor with C-inhibiting activity also promotes lysis 
of erythrocytes in fresh mammalian serum. Lysis-inducing activity of purified 
cobra venom factor was found in sera of lower vertebrates including the cyclos- 
tome hagfish and  in  invertebrates. Lysis-inducing activity was most effective 
with  frog serum.  Frog serum was found  to be more hemolytic for E s in  the 
presence of CVF than when cells were sensitized with hemolysin. The hemolysis 
induced by CVF with frog serum,  as in  the higher vertebrates, was inhibited 
when sera were pretreated with known C  inhibitors including heat,  chelators, 
endotoxin,  immune  complexes,  and  CVF  itself. 
Complexes formed with  CVF  and  either frog serum or invertebrate hemo- 
lymph promoted lysis of indicator cells in the presence of frog serum in EDTA. 
This lysis was most marked when the starfish-CVF complex was used and was 
C-dependent. Conversely, complex formed with frog serum and CVF promoted DAY, GEWURZ, JOHANNSEN, FINSTAD, AND GOOD  949 
lysis  of  E  in  the  presence  of  invertebrate  hemolymph  (Limulus)  in  EDTA. 
Hence,  serum  components were  to  some degree  at  least  interchangeable  be- 
tween vertebrate sera and invertebrate hemolymph. Lysis-inducing activity of 
purified CVF occurs in a wide range of species, has revealed activities resembling 
those  of  terminal  C-components in  lower vertebrates  and  invertebrates,  and 
provides one means for study of  C  and  C-like activities  in primitive species. 
The authors acknowledge the invaluable assistance given by Mrs. Linda Campbell during 
these studies. 
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